UiPath Inc. (PATH) Powers Banco Azteca's AI Transformation: Enhancing Efficiency and Service
UiPath Inc. (PATH) Honors Şişecam With AI25 Award for Transformative Automation in Hiring Processes
QBotica Named One of North America's Fastest-Growing Companies in the 2024 Deloitte Technology Fast 500
CGI Named UiPath Industry Solutions Partner of the Year in Global and EMEA Regions
UiPath (PATH) Receives a Rating Update From a Top Analyst
UiPath (PATH) Outperforms Broader Market: What You Need to Know
Analysis: With Musk in Tow, Trump Eyes Changes to Government Policies on AI and Its Dangers | CNN Business
What Does UiPath Inc.'s (NYSE:PATH) Share Price Indicate?
The Age of AI Is Still in the Early Innings. -2-
Will the frenzy of datacenters continue amid the slowdown of AI large model upgrades, Musk's "disruptive effect," and OpenAI's anxieties?
Due to the tight supply of high-quality data and the expensive construction costs of datacenters, the upgrade speed of AI large models is slowing down, which may, in turn, hinder the overall progress of the industry and datacenter development; at the same time, Musk's aggressive investment in datacenter construction may increase the expansion difficulties for other AI companies.
Alithya Group (ALYAF) Q2 Earnings Surpass Estimates
Gulf countries have a massive demand for AI computing power. nvidia (NVDA.US) and cloud giants sense the 'gold rush' vibe.
The global strategy of the Gulf countries is not groundless.
The AI Tipping Point: Half of CFOs Will Axe AI Investment If It Doesn't Show ROI Next Year
ARKK's Holdings Ranked by SA Quant Grades
Cathie Wood's ARK Innovation ETF Is a Trump Trade Winner as Tesla Soars. But It Still Lags the Market.
UiPath Inc. (PATH)'s AI Ambitions: Can New Leadership Revive This Struggling Stock?
UiPath Announces Third Quarter Fiscal 2025 Financial Results Conference Call
Beko Wins Prestigious AI25 Award From UiPath for Innovative Use of AI and Automation
How AI Could Help - or Threaten - the Fed's Interest-rate Moves
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500